Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 USD | +1.20% | -0.24% | -23.27% |
05-15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
04-30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.27% | 37.17M | |
+31.80% | 49.46B | |
+1.18% | 42.58B | |
+48.94% | 42.49B | |
-5.26% | 29.09B | |
+12.40% | 26.61B | |
-23.61% | 18.64B | |
+7.32% | 13.16B | |
+30.84% | 12.55B | |
+23.84% | 12.1B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Transcript : Marker Therapeutics, Inc. - Special Call